ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "socioeconomic factors"

  • Abstract Number: 1262 • ACR Convergence 2024

    The Relationship Between Child Opportunity Index and Burden of Pediatric Systemic Lupus Erythematosus

    Ayah Eltoum1, Livie Timmerman2, Melissa Mannion1 and Emily Smitherman1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Gardendale, AL

    Background/Purpose: Outcomes for systemic lupus erythematosus are known to be associated with sociodemographic indicators. The Child Opportunity Index (COI) is a well-validated measure of neighborhood…
  • Abstract Number: 2552 • ACR Convergence 2024

    Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program

    Haelynn Gim1, Rebecca Summit2, Karli Retzel2, Leah Santacroce2, Virginia Bills3, Nancy Shadick2, Sara Schoenfeld4 and Candace Feldman2, 1Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Mass General Brigham, Boston, MA, 4Massachusetts General Hospital, Boston, MA

    Background/Purpose: Social determinants of health (SDoH), including non-medical social needs and adverse environmental exposures, contribute to inequities in rheumatic disease care and outcomes. Patients with…
  • Abstract Number: 0205 • ACR Convergence 2024

    Cardiovascular Event Risks Among Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus

    Jean Park1, Cliff Rutter2, Elisea Avalos-Reyes3, Mary Anderson4, Will Cavers5, Dorothea Verbrugge6 and Kjel Johnson7, 1CVS Health, Hartford, CT, 2CVS Health, Fair Oaks Ranch, TX, 3CVS Health, Highland Village, TX, 4CVS Health, Irving, TX, 5CVS Health, Palm Beach Gardens, 6CVS Health, Salt Lake City, 7CVS Health, Tampa

    Background/Purpose: A growing body of evidence highlights a link between rheumatic diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PA), and systemic lupus erythematosus (SLE)…
  • Abstract Number: 1368 • ACR Convergence 2024

    Do CsDMARDs Still Play a Significant Role in Managing Rheumatoid Arthritis in the Current Biologic/JAKI Era? A Prospective Observational Study to Estimate the Extent of Response to Conventional Synthetic DMARDs in RA– Experience from a Tertiary Care Center in South India

    Prabhu Vasanth1, John Mathew2 and Divya K3, 1Christian Medical college , Vellore , India, Vellore, Tamil Nadu, India, 2Christian Medical college , Vellore , India, Vellore, India, 3Christian Medical College, Vellore, Tamil Nadu, India

    Background/Purpose: Conventional synthetic DMARDs remained the mainstay of treatment of RA for decades. However, their use has decreased recently due to the emergence of biological…
  • Abstract Number: 2588 • ACR Convergence 2024

    Examining the Influence of Socioeconomic Status on Osteoarthritis Prevalence and Risk Factors Among New York Residents

    Titilayo Adeniran1, David Cecil2 and Ahinee Amamoo3, 1Hospital for Special Surgery (HSS), New York, NY, 2Samford University, Birmingham, 3Samford University, Birmingham, AL

    Background/Purpose: Osteoarthritis (OA) is a chronic, progressive condition affecting the musculoskeletal system, significantly impacting the quality of life and mobility of millions worldwide. It is…
  • Abstract Number: 0616 • ACR Convergence 2024

    Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus

    Victoria Delk1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, North Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with the potential to severely diminish patients' quality of life (QoL). SLE disproportionately affects young…
  • Abstract Number: 1673 • ACR Convergence 2024

    Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States

    Chelsea Thompson1, iazsmin Ventura1, Cuoghi Edens2, Tamiko Katsumoto3 and Sowmya Popuri4, 1Section of Rheumatology, University of Chicago, Chicago, IL, 2Section of Pediatric Rheumatology, Section of Rheumatology, University of Chicago, Chicago, IL, 3Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA, 4Section of Internal Medicine, Loyola Medicine MacNeal, Maywood, IL

    Background/Purpose: In 2023, the American College of Rheumatology published a conditional recommendation for patients living with Rheumatoid Arthritis to follow a “Mediterranean style” diet. However,…
  • Abstract Number: 2592 • ACR Convergence 2024

    The Effects of Early Life Trauma and Socioeconomic Position on Systemic Lupus Erythematosus Risk in Adulthood

    Jennifer Woo1 and Dale Sandler2, 1Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, 2Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC

    Background/Purpose: Early life trauma (ELT) and neighborhood deprivation (ND)—a measure of socioeconomic position (SEP)—represent two aspects of the early life social environment that can be…
  • Abstract Number: 0668 • ACR Convergence 2024

    There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY

    Kiera Brennan1, Kai Sun2, Anitha Ramu1, Juliann Allen1, Justina Shafik1 and Noa Schwartz3, 1Albert Einstein College of Medicine, Bronx, NY, 2Duke University, Durham, NC, 3Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Nonadherence to hydroxychloroquine (HCQ) is associated with poor outcomes in SLE.1 Electronic Health Record (EHR) platforms collect data on patient medication access through dispensing…
  • Abstract Number: 1746 • ACR Convergence 2024

    Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Rheumatoid Arthritis

    Andreas Kerschbaumer1, Marlene Steiner2, Pascale Pruckner1, Josef Smolen3 and Daniel Aletaha4, 1Medical University of Vienna, Vienna, Wien, Austria, 2Medical University Vienna, Vienna, Wien, Austria, 3Medical University of Vienna, Vienna, Austria, 4Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Wien, Austria

    Background/Purpose: Therapeutic advances of the recent past have led to significant changes in clinical practice when treating patients with rheumatoid arthritis (RA). Since the advent…
  • Abstract Number: 2681 • ACR Convergence 2024

    Association of Social Determinants of Health with Systemic Lupus Erythematosus in the United States: Nationally Representative Estimates for 2017-2021

    Ami Vyas, Steven Cohen and Christine Eisenhower, University of Rhode Island, Kingston, RI

    Background/Purpose: Careful assessment of individuals’ social determinants of health (SDOH) that affect systemic lupus erythematosus (SLE) is crucial, as such evidence will improve care and…
  • Abstract Number: 0723 • ACR Convergence 2024

    Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis

    Warren RG James1, Corri Black1, Neil Basu2, Mark A Little3 and Rosemary Hollick1, 1University of Aberdeen, Aberdeen, United Kingdom, 2University of Glasgow, Glasgow, Scotland, United Kingdom, 3Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Increasing evidence suggests that socioeconomic status drives differences in outcomes for people with rheumatic conditions. Individuals with complex, rare rheumatic conditions such as antineutrophil…
  • Abstract Number: 1873 • ACR Convergence 2024

    Race/Ethnicity and Household Income at the County Level Interacts with the Association of Urbanicity and Lupus Nephritis Mortality

    Snehin Rajkumar1, Eric Yen2 and Ram Singh3, 1UCLA David Geffen School of Medicine, Irvine, CA, 2UCLA, Los Angeles, CA, 3UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: The reasons underlying substantial variation in lupus nephritis (LN) deaths by race/ethnicity remain largely unknown. There are no large population-based studies focused on the…
  • Abstract Number: 0184 • ACR Convergence 2023

    Material Need Insecurities Are Associated with Worse Patient-Reported Outcomes Among Individuals with SLE

    Donavon Sandoval-Heglund1, Eric Roberts2, Joonsuk Park2, Maria Dall'Era2, Kamil Barbour3, Cristina Lanata4, Kurt Greenlund3, Caroline Gordon5, Patti Katz6 and Jinoos Yazdany2, 1University of California San Francisco School of Medicine, La Quinta, CA, 2University of California San Francisco, San Francisco, CA, 3Centers for Disease Control and Prevention, Atlanta, GA, 4National Human Genome Research Institute, Washington, DC, 5Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 6University of California San Francisco, San Rafael, CA

    Background/Purpose: Lower socioeconomic status is associated with greater disease activity and mortality in systemic lupus erythematosus (SLE); however, mechanisms driving this are yet to be…
  • Abstract Number: 1029 • ACR Convergence 2023

    Social Determinants of Health in Children with Rheumatic Disease: A Single Center Cohort

    Kristina Ciaglia1, Elizabeth Sloan1 and Tracey Wright2, 1UT Southwestern and Scottish Rite for Children, Dallas, TX, 2UT Southwestern, Dallas, TX

    Background/Purpose: Rheumatic disease disproportionately impacts certain socioeconomic, racial, and ethnic groups frequently resulting in health care inequities. Social determinants of health (SDOH) are conditions in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology